Influenza affects 5-15% of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (> 65 y) is often low in Central and Eastern Europe (CEE); potentially because a paucity of country-specific data limits evidence-based policy making. Therefore the medical and economic burden of influenza were estimated in elderly populations in the Czech Republic, Hungary, Kazakhstan, Poland, Romania, and Ukraine. Data covering national influenza vaccination policies, surveillance and reporting, healthcare costs, populations, and epidemiology were obtained via literature review, open-access websites and databases, and interviews with experts. A simplified model of patient treatment flow incorporating cost, population, and incidence/prevalence data was used to calculate the influenza burden per country. In the elderly, influenza represented a large burden on the assessed healthcare systems, with yearly excess hospitalization rates of ~30/100,000. Burden varied between countries and was likely influenced by population size, surveillance system, healthcare provision, and vaccine coverage. The greatest burden was found in Poland, where direct costs were over EUR 5 million. Substantial differences in data availability and quality were identified, and to fully quantify the burden of influenza in CEE, influenza reporting systems should be standardized. This study most probably underestimates the real burden of influenza, however the public health problem is recognized worldwide, and will further increase with population aging. Extending influenza vaccination of the elderly may be a cost-effective way to reduce the burden of influenza in CEE.

1 Ya Horbachevsky Ternopil State Medical University; Ternopil Ukraine

Bela Johan National Center for Epidemiology; Budapest Hungary

ISPOR Chapter Kazakhstan; Astana Kazakhstan

Military Institute of Medicine; Warsaw Poland

National Institute of Public Health; Bucuresti Romania

National Institute of Public Health; Department of Infectious Diseases Epidemiology; Prague Czech Republic

Sanofi Pasteur; Lyon France

Syreon Research Institute; Budapest Hungary

Zobrazit více v PubMed

World Health Organization. Influenza. Fact Sheets. 2003. Available from: http://www.who.int/mediacentre/factsheets/2003/fs211/en/

Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121:258–64. doi: 10.1016/j.amjmed.2007.10.040. PubMed DOI PMC

World Health Organization. Comparing deaths from pandemic and seasonal influenza. Global Alert and Response. 2009. Available from: http://www.who.int/csr/disease/swineflu/notes/briefing_20091222/en/

Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006;194(Suppl 2):S82–91. doi: 10.1086/507558. PubMed DOI

Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86. doi: 10.1001/jama.289.2.179. PubMed DOI

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–96. doi: 10.1016/j.vaccine.2007.03.046. PubMed DOI

Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 2004;103:133–8. doi: 10.1016/j.virusres.2004.02.025. PubMed DOI

Webster RG. Immunity to influenza in the elderly. Vaccine. 2000;18:1686–9. doi: 10.1016/S0264-410X(99)00507-1. PubMed DOI

Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ. 2012;345:e4445. doi: 10.1136/bmj.e4445. PubMed DOI PMC

Gasparini R, Amicizia D, Lai PL, Panatto D. Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly. Hum Vaccin Immunother. 2012;8:21–8. doi: 10.4161/hv.8.1.17622. PubMed DOI

Brydak L, Roiz J, Faivre P, Reygrobellet C. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis. Clin Drug Investig. 2012;32:73–85. doi: 10.2165/11594030-000000000-00000. PubMed DOI

Jahnz-Rózyk K. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland] Pol Merkuriusz Lek. 2010;29:37–40. PubMed

Lanzieri G. The greying of the baby boomers, a century-long view of ageing in European populations. Statistics in Focus 2011; 23. Available from: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-11-023/EN/KS-SF-11-023-EN.PDF

Mereckiene J, Cotter S, Weber JT, Nicoll A, Lévy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, et al. VENICE Gatekeepers Group Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill. 2008;13:19001. PubMed

Rechel B, Doyle Y, Grundy E, McKee M. How can health systems respond to population ageing? World Health Organization 2009 and World Health Organization, on behalf of the European Observatory on Health Systems and Policies; 2009. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/64966/E92560.pdf

World Health Organization Influenza vaccines: WHO position paper. Wkly Epidemiol Rec. 2005;33:279–87.

Blank P, Schwenkglenks M, Szucs TD. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother. 2012;8:328–35. doi: 10.4161/hv.18629. PubMed DOI

World Health Organization-Europe. WHO/Europe recommendations on influenza vaccination during the 2011-2012 winter season. 2011. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/152297/EURO_2011_2012-flu-vacc-rec_V2.pdf

Centers for Disease Control and Prevention (CDC) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1128–32. PubMed

The Council of the European Union. Council recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/EU). Official Journal of the European Union. 2009. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF

Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–76. PubMed

Jansen AG, Sanders EA, Nichol KL, van Loon AM, Hoes AW, Hak E. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine. 2008;26:5567–74. doi: 10.1016/j.vaccine.2008.08.003. PubMed DOI

Boyle JR, Sparks RS, Keijzers GB, Crilly JL, Lind JF, Ryan LM. Prediction and surveillance of influenza epidemics. Med J Aust. 2011;194:S28–33. PubMed

EuroFlu. The influenza season has begun in the WHO European Region EuroFlu Electronic Bulletin. 2012. Available from: http://www.euroflu.org/cgi-files/bulletin_v2.cgi?display=1&code=467&bulletin=467

EuroFlu. Low and decreasing influenza activity in most countries of the WHO European Region. EuroFlu Electronic Bulletin. 2012. Available from: https://www.isirv.org/cgi-files/bulletin_v2.cgi?display=1&code=442&bulletin=442

O’Flanagan DC, Cotter S, Mereckiene J. Vaccine European New Integrated Collaboration Effort (VENICE). Pandemic A(H1N1)2009 influenza vaccination survey, influenza season 2009/2010. VENICE. 2011. Available from: http://venice.cineca.org/Final_Report_VENICE_Pandemic_Influenza_2009.pdf

European Centre for Disease Prevention and Control. Influenza vaccines from a public health perspective: Where are we today? Stockholm, 2012. Available from: http://www.ecdc.europa.eu/en/aboutus/organisation/director%20speeches/ecdc-director--seasonal-influenza-ivw-2012oct10.pdf

Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine. 2002;20:2562–78. doi: 10.1016/S0264-410X(02)00154-8. PubMed DOI

World Health Organization. Clinical management of influenza and other acute respiratory illness in resource-limited settings: learning from the influenza pandemic (H1N1) 2009. Meeting Report. Geneva, 2010. Available from: http://www.who.int/influenza/patient_care/clinical/858-WHOGIPReport_A4_WEB_FA.pdf

Cernescu C, Ruta S-M. Distinctive features in the evolution of 2009 influenza pandemic in East European countries. Proc Rom Acad, Series B. 2010;2:99–106.

Ercole A, Taylor BL, Rhodes A, Menon DK. Modelling the impact of an influenza A/H1N1 pandemic on critical care demand from early pathogenicity data: the case for sentinel reporting. Anaesthesia. 2009;64:937–41. doi: 10.1111/j.1365-2044.2009.06070.x. PubMed DOI

van Noort SP, Muehlen M, Rebelo de Andrade H, Koppeschaar C, Lima Lourenço JM, Gomes MG. Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe. Euro Surveill. 2007;12:E5–6. PubMed

Friesema IH, Koppeschaar CE, Donker GA, Dijkstra F, van Noort SP, Smallenburg R, van der Hoek W, van der Sande MA. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine. 2009;27:6353–7. doi: 10.1016/j.vaccine.2009.05.042. PubMed DOI

Tilston NL, Eames KT, Paolotti D, Ealden T, Edmunds WJ. Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health. 2010;10:650. doi: 10.1186/1471-2458-10-650. PubMed DOI PMC

Marquet RL, Bartelds AI, van Noort SP, Koppeschaar CE, Paget J, Schellevis FG, van der Zee J. Internet-based monitoring of influenza-like illness (ILI) in the general population of the Netherlands during the 2003-2004 influenza season. BMC Public Health. 2006;6:242. doi: 10.1186/1471-2458-6-242. PubMed DOI PMC

U.S. Department of Labor. Bureau of Labor Statistics. Illness-related work absences during flu season. Issues in Labor Statistics. 2010. Available from: http://www.bls.gov/opub/ils/pdf/opbils83.pdf

Shellenback K. Child care & parent productivity: making the business case. Linking economic development and child care research project. Ithaca (NY): Cornell University, Cornell Cooperative extension department of city and regional planning. 2004. Available from: http://annazavaritt.blog.ilsole24ore.com/files/making-the-business-case-2.pdf

Jefferson T. Influenza vaccination: policy versus evidence. BMJ. 2006;333:912–5. doi: 10.1136/bmj.38995.531701.80. PubMed DOI PMC

Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010:CD004876. PubMed

Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D, Oroszi B, Nunes B, Savulescu C, Mazick A, et al. “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill. 2009;14:19388. PubMed

Gasparini R, Amicizia D, Lai PL, Rossi S, Panatto D. Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study. Hum Vaccin Immunother. 2013;9:144–52. doi: 10.4161/hv.22231. PubMed DOI PMC

Thompson M. Updated Adjusted Estimates of 2012-13 Seasonal Influenza Vaccine Effectiveness in the United States. 2013 National adult immunization summit. Atlanta, Georgia, 2013.

Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Pérez-Vilar S, Micó-Esparza JL, Belenguer-Varea A, Carratalá-Munuera C, Gil-Guillén V, Schwarz-Chavarri H. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine. 2012;30:5714–20. doi: 10.1016/j.vaccine.2012.07.006. PubMed DOI PMC

Antunes JL, Waldman EA, Borrell C, Paiva TM. Effectiveness of influenza vaccination and its impact on health inequalities. Int J Epidemiol. 2007;36:1319–26. doi: 10.1093/ije/dym208. PubMed DOI

Health Protection Agency. Royal College of General Practitioners Weekly Returns Service. 2013.

Fleming DM, van der Velden J, Paget WJ. The evolution of influenza surveillance in Europe and prospects for the next 10 years. Vaccine. 2003;21:1749–53. doi: 10.1016/S0264-410X(03)00066-5. PubMed DOI

Nielen MMJ, Spreeuwenberg P, Paget JW, Donker GA, Meijer A, Schellevis FG, Fleming D. The age-sepcofoc impact of influenza on hospital admissions and mortality in five countries in Europe. 2010. Utrecht, NIVEL.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine. 2006;24:6812–22. doi: 10.1016/j.vaccine.2006.07.042. PubMed DOI

Kardas P, Zasowska A, Dec J, Stachurska M. Reasons for low influenza vaccination coverage: cross-sectional survey in Poland. Croat Med J. 2011;52:126–33. doi: 10.3325/cmj.2011.52.126. PubMed DOI PMC

Kanitz EE, Wu LA, Giambi C, Strikas RA, Levy-Bruhl D, Stefanoff P, Mereckiene J, Appelgren E, D’Ancona F, VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine. 2012;30:5222–8. doi: 10.1016/j.vaccine.2012.06.012. PubMed DOI

Groenewold M, Baron S, Tak S, Allred N. Influenza vaccination coverage among US nursing home nursing assistants: the role of working conditions. J Am Med Dir Asso. 2012;13:85.e17–23. doi: 10.1016/j.jamda.2011.02.008. PubMed DOI

Kardas P, Zasowska A, Dec J, Stachurska M. Reasons for low influenza vaccination coverage: cross-sectional survey in Poland. Croat Med J. 2011;52:126–33. doi: 10.3325/cmj.2011.52.126. PubMed DOI PMC

Mangtani P, Breeze E, Stirling S, Hanciles S, Kovats S, Fletcher A. Cross-sectional survey of older peoples’ views related to influenza vaccine uptake. BMC Public Health. 2006;6:249. doi: 10.1186/1471-2458-6-249. PubMed DOI PMC

Seale H, Heywood AE, McLaws ML, Ward KF, Lowbridge CP, Van D, MacIntyre CR. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis. 2010;10:99. doi: 10.1186/1471-2334-10-99. PubMed DOI PMC

Patel MS, Davis MM. Could a federal program to promote influenza vaccination among elders be cost-effective? Prev Med. 2006;42:240–6. doi: 10.1016/j.ypmed.2005.12.004. PubMed DOI

Postma MJ, Baltussen RP, Palache AM, Wilschut JC. Further evidence for favorable cost-effectiveness of elderly influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2006;6:215–27. doi: 10.1586/14737167.6.2.215. PubMed DOI

Wang ST, Lee LT, Chen LS, Chen TH. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Vaccine. 2005;23:1973–80. doi: 10.1016/j.vaccine.2004.10.011. PubMed DOI

World Health Organization Meeting of the strategic advisory group of experts on immunization, april 2012 – conclusions and recommendations. Wkly Epidemiol Rec. 2012;87:201–16. PubMed

The European Commission. Healthy Ageing – A Challenge for Europe. In: AGE European Older People’s Platform, EuroHealthNet, World Health Organization, Austrian Health Promotion Foundation, National Institute of Public Health (Czech Republic), The Health Development Agency (England), et al., eds.: The Swedish National Institute of Public Health, 2007.

Gomez AI. European Innovation Partnership on Active and Healthy Ageing (AHAIP). EU Health Policy Forum. Brussels, 2010.

Bryndova L, Pavlokova K, Roubal T. Czech Republic: Health system review. Health System in Transition, 2009:1-122. PubMed

Gaál P, Szigeti S, Csere M, Gaskins M, Panteli D. Hungary health system review. Health Syst Transit. 2011;13:1–266. PubMed

Katsaga A, Kulzhanov M, Karanikolos M. Kazakhstan: Health system review. Health System in Transition. 2012;14:1–154. PubMed

Sagan A, Panteli D, Borkowski W, Dmowski M, Domanski F, Czyzewski M, Gorynski P, Karpacka D, Kiersztyn E, Kowalska I, et al. Poland health system review. Health Syst Transit. 2011;13:1–193. PubMed

Vlădescu C, Scîntee G, Olsavszky V. Romania: Health system review. Health Systems in Transition. 2008;10:1–172. PubMed

Lekhan V, Rudiy V, Richardson E. Ukraine: Health system review. Health Syst Transit. 2010;12:1–183, xiii-xiv. PubMed

Kyncl J, Paget WJ, Havlickova M, Kriz B. Harmonisation of the acute respiratory infection reporting system in the Czech Republic with the European community networks. Euro Surveill. 2005;10:30–3. PubMed

World Health Organization-Europe. Overview of sentinel systems for hospitalized severe acute respiratory infections (SARI) presented in the weekly EuroFlu surveillance bulletin. 2012. Available from: http://www.euro.who.int/__data/assets/pdf_file/0005/186863/Overview-of-SARI-Surveillance-Systems-final.pdf

Romanowska M, Nowak I, Rybicka K, Brydak LB. The introduction of the SENTINEL influenza surveillance system in Poland--experiences and lessons learned from the first three epidemic seasons. Euro Surveill. 2008;13:8046. PubMed

Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016